News

Wegovy maker Novo Nordisk to reduce costs after $95 billion stock loss
Wegovy-maker Novo Nordisk said on Wednesday it will sharpen its commercial focus and reduce costs, after a major profit ...
What's Going On With Novo Nordisk Stock?
The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… ...
Novo Nordisk Is Now A Better Value Play Than Eli Lilly With Solid Upside
Novo Nordisk is misunderstood by the market, creating a rare asymmetric value opportunity. Read why I rate NVO stock a Buy ...
Novo Nordisk shares dip further as Wegovy gains nearly erased
Shares in Novo Nordisk fell as much as 6% on Friday before recovering some ground later in the session, extending recent ...
Novo Nordisk Shares Plummet as Competition Weighs on Sales
The pharmaceutical giant cut its guidance and said U.S. sales of Ozempic grew more slowly.
Ozempic maker Novo Nordisk has its worst day since Black Monday
Shares of Novo Nordisk skidded on Tuesday as the Danish drugmaker reduced its expectations on wildly popular drugs Ozempic ...
Stock zoom: Novo’s plight offers a lesson on managing market expectations
This maker of weight-loss drugs saw its share price zoom and then crash. The CEO has been replaced. The incoming boss will ...
Wegovy maker Novo hit with investor class action over revenue forecast cut
Novo Nordisk , maker of the weight-loss drug Wegovy, has been sued in U.S. court by investors claiming the Danish ...